ArticleMolecular therapy. Oncology2026

Unmasking Wnt-driven HCC: Inhibiting SMYD2 to overcome immune resistance.

Xiupeng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.